Abstract
The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) are accredited against International Standard (ISO/IEC) 17043 Conformity assessment – General requirements for proficiency testing. In 2017, the RCPAQAP began collaborating with the United Kingdom National External Quality Assessment Services for Immunocytochemistry and In-Situ Hybridisation (UK NEQAS ICC and ISH) for technical proficiency testing in PD-L1 for non-small cell lung cancer (NSCLC). RCPAQAP laboratories participating in the program has increased steadily over the last few years to 43 in 2021; 2018–2020 results will show that RCPAQAP participant results are comparable with results from the total number of 153 UK NEQAS participants.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.